Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions
Open Access
- 1 December 2007
- journal article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 4 (12), e348
- https://doi.org/10.1371/journal.pmed.0040348
Abstract
The authors discuss humoral immune responses to HIV and approaches to designing vaccines that induce viral neutralizing and other potentially protective antibodies.Keywords
This publication has 53 references indexed in Scilit:
- Broad HIV-1 neutralization mediated by CD4-binding site antibodiesNature Medicine, 2007
- Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunizationProceedings of the National Academy of Sciences of the United States of America, 2007
- Monoclonal Antibodies to Phosphatidylinositol Phosphate Neutralize Human Immunodeficiency Virus Type 1: Role of Phosphate-Binding SubsitesJournal of Virology, 2007
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007
- Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodiesVirology, 2007
- Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern AfricaJournal of Virology, 2006
- A worldwide survey of haplotype variation and linkage disequilibrium in the human genomeNature Genetics, 2006
- Nonneutralizing Antibodies Are Able To Inhibit Human Immunodeficiency Virus Type 1 Replication in Macrophages and Immature Dendritic CellsJournal of Virology, 2006
- Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody ResponsesJournal of Virology, 2006
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004